Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2002 Feb;78(1):18–19. doi: 10.1136/sti.78.1.18

An update on pelvic inflammatory disease

J Ross 1
PMCID: PMC1763681  PMID: 11872852

Full Text

The Full Text of this article is available as a PDF (66.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bevan C. D., Johal B. J., Mumtaz G., Ridgway G. L., Siddle N. C. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet Gynaecol. 1995 May;102(5):407–414. doi: 10.1111/j.1471-0528.1995.tb11294.x. [DOI] [PubMed] [Google Scholar]
  2. Brunham R. C., Binns B., Guijon F., Danforth D., Kosseim M. L., Rand F., McDowell J., Rayner E. Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis. 1988 Sep;158(3):510–517. doi: 10.1093/infdis/158.3.510. [DOI] [PubMed] [Google Scholar]
  3. Farley T. M., Rosenberg M. J., Rowe P. J., Chen J. H., Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet. 1992 Mar 28;339(8796):785–788. doi: 10.1016/0140-6736(92)91904-m. [DOI] [PubMed] [Google Scholar]
  4. Gareen I. F., Greenland S., Morgenstern H. Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990. Epidemiology. 2000 Sep;11(5):589–597. doi: 10.1097/00001648-200009000-00016. [DOI] [PubMed] [Google Scholar]
  5. Grimes D. A., Schulz K. F. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev. 2000;(2):CD001327–CD001327. doi: 10.1002/14651858.CD001327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hillis S. D., Joesoef R., Marchbanks P. A., Wasserheit J. N., Cates W., Jr, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol. 1993 May;168(5):1503–1509. doi: 10.1016/s0002-9378(11)90790-x. [DOI] [PubMed] [Google Scholar]
  7. Hubacher D., Lara-Ricalde R., Taylor D. J., Guerra-Infante F., Guzmán-Rodríguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 2001 Aug 23;345(8):561–567. doi: 10.1056/NEJMoa010438. [DOI] [PubMed] [Google Scholar]
  8. Jacobson L., Weström L. Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol. 1969 Dec 1;105(7):1088–1098. doi: 10.1016/0002-9378(69)90132-x. [DOI] [PubMed] [Google Scholar]
  9. Jamieson D. J., Duerr A., Macasaet M. A., Peterson H. B., Hillis S. D. Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease. Infect Dis Obstet Gynecol. 2000;8(2):88–93. doi: 10.1002/(SICI)1098-0997(2000)8:2<88::AID-IDOG5>3.0.CO;2-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lee N. C., Rubin G. L., Borucki R. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study. Obstet Gynecol. 1988 Jul;72(1):1–6. [PubMed] [Google Scholar]
  11. Molander P., Sjöberg J., Paavonen J., Cacciatore B. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease. Ultrasound Obstet Gynecol. 2001 Mar;17(3):233–238. doi: 10.1046/j.1469-0705.2001.00353.x. [DOI] [PubMed] [Google Scholar]
  12. Morcos R., Frost N., Hnat M., Petrunak A., Caldito G. Laparoscopic versus clinical diagnosis of acute pelvic inflammatory disease. J Reprod Med. 1993 Jan;38(1):53–56. [PubMed] [Google Scholar]
  13. Ness R. B., Soper D. E., Holley R. L., Peipert J., Randall H., Sweet R. L., Sondheimer S. J., Hendrix S. L., Amortegui A., Trucco G. Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study. Am J Obstet Gynecol. 2001 Jul;185(1):121–127. doi: 10.1067/mob.2001.115114. [DOI] [PubMed] [Google Scholar]
  14. Peipert J. F., Ness R. B., Blume J., Soper D. E., Holley R., Randall H., Sweet R. L., Sondheimer S. J., Hendrix S. L., Amortegui A. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol. 2001 Apr;184(5):856–864. doi: 10.1067/mob.2001.113847. [DOI] [PubMed] [Google Scholar]
  15. Sellors J., Mahony J., Goldsmith C., Rath D., Mander R., Hunter B., Taylor C., Groves D., Richardson H., Chernesky M. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):113–120. doi: 10.1016/0002-9378(91)90639-9. [DOI] [PubMed] [Google Scholar]
  16. Shih S., Li-Juan Q., Xuan L. Comparative clinical experience with 3 IUDs, TCu 380 Ag, TCu 220C and Mahua ring, in Tianjin, People's Republic of China. Contraception. 1984 Mar;29(3):229–239. doi: 10.1016/s0010-7824(84)80003-7. [DOI] [PubMed] [Google Scholar]
  17. Soper D. E., Brockwell N. J., Dalton H. P. Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. Am J Obstet Gynecol. 1992 Sep;167(3):653–660. doi: 10.1016/s0002-9378(11)91566-x. [DOI] [PubMed] [Google Scholar]
  18. Walsh T., Grimes D., Frezieres R., Nelson A., Bernstein L., Coulson A., Bernstein G. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet. 1998 Apr 4;351(9108):1005–1008. doi: 10.1016/s0140-6736(97)09086-7. [DOI] [PubMed] [Google Scholar]
  19. Washington A. E., Gove S., Schachter J., Sweet R. L. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection. JAMA. 1985 Apr 19;253(15):2246–2250. [PubMed] [Google Scholar]
  20. Weström L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol. 1975 Mar 1;121(5):707–713. doi: 10.1016/0002-9378(75)90477-9. [DOI] [PubMed] [Google Scholar]
  21. Wølner-Hanssen P., Eschenbach D. A., Paavonen J., Kiviat N., Stevens C. E., Critchlow C., DeRouen T., Holmes K. K. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA. 1990 Jan 5;263(1):54–59. doi: 10.1001/jama.1990.03440010052029. [DOI] [PubMed] [Google Scholar]
  22. Wølner-Hanssen P. Oral contraceptive use modifies the manifestations of pelvic inflammatory disease. Br J Obstet Gynaecol. 1986 Jun;93(6):619–624. doi: 10.1111/j.1471-0528.1986.tb08036.x. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES